echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Cardiovasc Diabetol: Diabetes and risk of amputation!

    Cardiovasc Diabetol: Diabetes and risk of amputation!

    • Last Update: 2022-01-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Peripheral arterial disease (PAD) is an atherosclerotic occlusive disease of the lower extremities that affects hundreds of millions of people worldwide
    .


    Its most severe presentation is chronic limb-threatening ischemia (CLTI), defined as the presence of ischemic rest pain, lower extremity ulceration, or gangrene lasting more than 2 weeks


    Peripheral arterial disease (PAD) is an atherosclerotic occlusive disease of the lower extremities that affects hundreds of millions of people worldwide


    Singapore has one of the highest rates of LEA due to diabetes (14.


    In the population-based Singapore Chinese Health Study, researchers investigated diabetes and its interrelationships with hypertension
    , body mass index (BMI) and smoking, and the risk of LEA due to CLTI .


    Participants were interviewed at the time of recruitment (1993 to 1998), and 656 LEA event cases were identified in 2017 through linkage to a national hospital database


    In the population-based Singapore Chinese Health Study, researchers investigated diabetes and its interrelationships with hypertension


    The results showed that the HR (95% CI) for LEA risk was 13.


    Kaplan-Meier survival curve of lower limb amputation for chronic limb-threatening ischemia (CLTI) in patients with a history of diabetes mellitus

    Lower limb amputation for chronic limb-threatening ischemia (CLTI) in patients with a history of diabetes Kaplan-Meier survival curve for chronic limb-threatening ischemia (CLTI) in patients with a history of diabetes Kaplan-Meier survival curve of blood (CLTI)

    Overall, although diabetes increased the risk of developing LEA more than tenfold, increased hypertension and BMI did not further increase the risk of developing LEA in patients with diabetes, suggesting a common mechanistic pathway for these risk factors
    .


    In contrast, smoking may work through another pathway, so smoking increases LEA risk regardless of diabetes status


    Overall, although diabetes increased the risk of developing LEA more than tenfold, increased hypertension and BMI did not further increase the risk of developing LEA in patients with diabetes, suggesting a common mechanistic pathway for these risk factors


    Reference: Ying, AF, Tang, TY, Jin, A.
    et al.
    Diabetes and other vascular risk factors in association with the risk of lower extremity amputation in chronic limb-threatening ischemia: a prospective cohort study.
    Cardiovasc Diabetol 21, 7 (2022).
    https://doi.
    org/10.
    1186/s12933-021-01441-0 Reference: Ying, AF, Tang, TY, Jin, A.
    et al.
    Diabetes and other vascular risk factors in association with the risk of lower extremity amputation in chronic limb-threatening ischemia: a prospective cohort study.
    Cardiovasc Diabetol 21, 7 (2022).
    https://doi.
    org/10.
    1186/s12933-021-01441-0Reference: Ying, AF, Tang, TY, Jin, A.
    et al.
    Diabetes and other vascular risk factors in association with the risk of lower extremity amputation in chronic limb-threatening ischemia: a prospective cohort study.
    Cardiovasc Diabetol 21, 7 (2022).
    https://doi.
    org/10.
    1186/s12933-021-01441-0 https://doi.
    org/10.
    1186/s12933-021-01441-0 Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.